184
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Extended versus superextended lymph-node dissection in radical cystectomy: subgroup analysis of possible recurrence-free survival benefit

, &
Pages 175-180 | Received 02 Aug 2015, Accepted 10 Dec 2015, Published online: 06 Apr 2016

References

  • Witjes JA, Compérat E, Cowan NC, De Santis M, Gakis G, Lebret T, et al., European Association of Urology. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 2014;65:778–92.
  • Holmer M, Bendahl P-O, Davidsson T, Gudjonsson S, Månsson W, Liedberg F. Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference? World J Urol 2009;27:521–6.
  • Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008;179:873–8.
  • Jensen JB, Ulhøi BP, Jensen KM-E. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival. Int J Urol 2012;19:39–47.
  • Zehnder P, Studer UE, Skinner EC, Dorin RP, Cai J, Roth B, et al., Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 2011;186:1261–8.
  • Poulsen AL, Horn T, Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998;160:2015–20.
  • Bruins HM, Veskimae E, Hernandez V, Imamura M, Neuberger MM, Dahm P. et al., The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review. Eur Urol 2014;66:1065–77.
  • Zlotta AR. Limited, extended, superextended, megaextended pelvic lymph node dissection at the time of radical cystectomy: what should we perform? Eur Urol 2012;61:243–4.
  • Jensen JB, Ulhøi BP, Jensen KM-E. Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery. BJU Int 2010;106:199–205.
  • Jensen JB, Ulhøi BP, Jensen KM-E. Evaluation of different lymph node (LN) variables as prognostic markers in patients undergoing radical cystectomy and extended LN dissection to the level of the inferior mesenteric artery. BJU Int 2012;109:388–93.
  • Sobin LH, Gospodarowicz MK, Wittekind Ch, Eds. TNM Classification of Malignant Tumors, 7th ed. Wiley-Blackwell, Oxford (2009)
  • Sternberg CN, Skoneczna I, Kerst JM, Albers P, Fossa SD, Agerbaek M, et al., European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group; Groupe d'Etude des Tumeurs Urogénitales; National Cancer Research Institute Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; German Association of Urologic Oncology. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N + M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial. Lancet Oncol 2015;16:76–86.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.